Angelini Pharma’s Ontozry available for patients in Scotland with drug-resistant epilepsy
Summary : SMC accepts promising new therapy which offers a better quality of life to patients with epilepsy Around 55,000 people in…
Summary : SMC accepts promising new therapy which offers a better quality of life to patients with epilepsy Around 55,000 people in…